Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0029 Transporter Info
Gene Name SLCO1A2
Transporter Name Organic anion transporting polypeptide 1A2
Gene ID
6579
UniProt ID
P46721
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Bifidobacterium

     Bifidobacterium animalis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [1]

Detailed Description

 The Bifidobacterium animalis subsp. lactis Bi-07 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

     Bifidobacterium longum 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [1]

Detailed Description

 The Bifidobacterium longum subsp. infantis has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacillota

   Genus: Enterocloster

     Enterocloster bolteae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [1]

Detailed Description

 The Enterocloster bolteae WAL 16351 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

   Genus: Lacrimispora

     Lacrimispora saccharolytica 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [1]

Detailed Description

 The Lacrimispora saccharolytica WM1 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Bacteroidota

   Genus: Bacteroides

     Bacteroides uniformis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [1]

Detailed Description

 The Bacteroides uniformis CL03T00C23 has been reported to sequester the drug Montelukast, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Pseudomonadota

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence 1

 Co-transport of human SLCO1A2 substrates/drugs in the health condition [2]

Regulating Factor
ompF

Detailed Description

 The protein ompF of Escherichia coli JM712 has been reported to transport similar substrates/drugs of SLCO1A2, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence 2

 Sequestration of human SLCO1A2 substrates/drugs in the health condition [3]

Detailed Description

 The Escherichia coli str. K-12 substr. MG1655 has been reported to sequester the drug Ciprofloxacin, which limits the distribution of the drug in the body and its binding to the drug transporter SLCO1A2, thereby affecting the efficacy, safety, or bioavailability of the drug.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 7 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLCO1A2 expression in the health condition [4] , [5]

Regulating Factor
Trimethylamine oxide

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite trimethylamine oxide generated from the metabolism of l-carnitine by the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLCO1A2.

       Microbe Influence 2

 Up regulating of SLCO1A2 expression in the health condition [6]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1A2.

       Microbe Influence 3

 Up regulating of SLCO1A2 expression in the health condition [6]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1A2.

       Microbe Influence 4

 Up regulating of SLCO1A2 expression in the health condition [6]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1A2.

       Microbe Influence 5

 Up regulating of SLCO1A2 expression in the health condition [6]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1A2.

       Microbe Influence 6

 Up regulating of SLCO1A2 expression in the health condition [6]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Studied Tissue

 Liver

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1A2.

       Microbe Influence 7

 Down regulating of SLCO1A2 expression in conventional mice compared with germ-free mice [7] , [8]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 Swiss Webster mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLCO1A2.
References
1 Bioaccumulation of therapeutic drugs by human gut bacteria. Nature. 2021 Sep;597(7877):533-538.
2 The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother. 1993 Aug;32(2):195-213.
3 Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017 May 18;545(7654):299-304.
4 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
5 Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013 May;19(5):576-85.
6 Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022 Sep;237:108238.
7 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
8 Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013 Feb 5;17(2):225-35.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.